3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Burkitt Lymphoma
14
Vomiting
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Nausea
5
Leukemia
5
Recurrence
4
Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia, Biphenotypic, Acute
3
Immunoglobulin Light-chain Amyloidosis
3
Breast Neoplasms
3
Blast Crisis
3
Smoldering Multiple Myeloma
2
Sarcoma
2
Prostatic Neoplasms
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmacytoma
2
Ovarian Neoplasms
2
Neoplasms, Plasma Cell
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Interventions
Temozolomide
115
Bevacizumab
72
Radiotherapy
52
Radiation
23
Erlotinib Hydrochloride
13
Lomustine
12
pembrolizumab
11
Magnetic Resonance Spectroscopy
11
Vorinostat
10
Nivolumab
10
Surgical Procedures, Operative
9
Irinotecan
9
Sorafenib
8
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
7
Immunoglobulin G
7
Everolimus
7
Drug Therapy
7
Disulfides
7
Radiosurgery
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Carmustine
6
antineoplaston AS 2-1
5
antineoplaston A10
5
Sirolimus
5
Cilengitide
5
veliparib
4
veledimex
4
temsirolimus
4
selinexor
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Glioblastoma
×
dexamethasone acetate
×
Clear all
No trials found.